RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    500+ gather in Amsterdam for Euro Convergence, RAPS’ largest-ever European event

    RAPS today wrapped up the final day of Euro Convergence 2022, which took place live and in-person in Amsterdam after being held virtually the previous two years. Euro Convergence is the premier annual event for European regulatory professionals. This year’s event drew more than 500 participants from six continents and 33 countries. Attendees gathered for three days of education sessions, expert presentations and panel discussions curated exclusively by European regulato...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAPS Euro Convergence features speakers from EMA, FDA, and Swiss, Austrian and UK health authorities, as well as notified bodies

    Prominent officials from the European Medicines Agency (EMA), the US Food and Drug Administration (FDA), Swiss, Austrian and UK national health authorities, and several notified bodies will speak at the upcoming RAPS Euro Convergence . The annual three-day conference devoted to European healthcare product regulations and regulatory issues will take place, 10–12 May in Amsterdam. More than 120 expert speakers will provide updates and insights on important European regul...
  • RAPS' LatestRAPS' Latest
    RAPS AnnouncementsRAPS Announcements

    FDA continues co-sponsorship of MedCon conference with AFDO/RAPS Healthcare Products Collaborative

    The US Food and Drug Administration (FDA) will continue its longstanding co-sponsorship of the MedCon conference . With a focus on fostering open discussions of the most pressing issues facing the medical device industry, the AFDO/RAPS Healthcare Products Collaborative recently announced that their new partnership will carry on Xavier Heath’s 12-year legacy of delivering the MedCon conference. The MedCon 2022 Conference will be held virtually 4 – 6 May 2022. The even...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    132 professionals pass Regulatory Affairs Certification (RAC) exams, earning RAC-Devices or RAC-Drugs credentials

    RAPS today announced the names of the 132 professionals who passed one of the two Regulatory Affairs Certification (RAC) exams in autumn 2021. By passing, they earn either the RAC-Drugs or RAC-Devices credential. The RAC credentials are the leading certifications for regulatory professionals in the healthcare product sector and the only regulatory credentials in this sector to be accredited through the National Commission for Certifying Agencies (NCCA). Earning an RAC...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAPS and AFDO partner to further healthcare products industry dialogue, including MedCon conference

    RAPS and the Association of Food and Drug Officials (AFDO) have come together to support sharing, collaboration and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s 12-year legacy of delivering the Xavier MedCon Conference . “The annual MedCon Conference has historically provided outreach and ...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAC receives accreditation from National Commission for Certifying Agencies

    RAPS today announced that its Regulatory Affairs Certification (RAC) programs have been accredited through the National Commission for Certifying Agencies (NCCA) , an accrediting body of the Institute for Credentialing Excellence (ICE). NCCA accreditation applies to both the RAC-Drugs and RAC-Devices credentials. NCCA accreditation provides independent, impartial validation that the RAC programs meet stringent industry standards for certification programs. Accreditati...
  • RAPS' LatestRAPS' Latest
    RAPS AnnouncementsRAPS Announcements

    108 more professionals earn RAC

    RAPS today announced that 108 professionals passed the Regulatory Affairs Certification (RAC) exams in the summer exam window, which occurred in July and August 2021. Passing the exam confers the RAC-Drugs and RAC-Devices credentials, the leading credentials for regulatory professionals in the healthcare product sector. There are currently more than 5,000 professionals around the world who hold the RAC credentials.   The RAC exams are rigorous and in order to pass, o...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAPS releases updated Regulatory Competency Framework

    RAPS today announced the release of its updated Regulatory Competency Framework , describing the essential elements of what is required of regulatory professionals at four key career and professional levels. The framework is relevant to regulatory professionals in multiple healthcare product sectors, including pharmaceuticals, medical devices and biotech, and is useful to individual professionals, hiring managers and organizations. “The Regulatory Competency Framework ...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAPS Convergence 2021 brings regulatory community together virtually to hear from regulators, learn from each other and celebrate the profession

    RAPS today wrapped up its annual RAPS Convergence , the world’s largest conference dedicated to healthcare product regulation and regulatory issues. The event drew more than 1,500 participants again this year—from 37 countries around the globe—in the second year it was held virtually. Convergence 2021 attendees heard from more than 300 expert speakers, including more than 50 from national and regional health authorities and notified bodies from around the world. More t...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    Global regulatory workforce nearly 100K, says new report from RAPS, Elemed

    Nearly 100,000 professionals around the world currently work in the field of regulatory affairs for healthcare products, such as pharmaceuticals, medical devices, and biotechnology products, including vaccines. This is according to a new joint report from RAPS and Elemed , a leading technical recruiter specializing in regulatory affairs. The Global Regulatory Affairs Professionals Workforce report, previewed this week at the RAPS Convergence 2021 virtual conference...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    RAPS honors 7 distinguished individuals and an advocacy group for contributions to the regulatory profession and patient health

    RAPS has recognized seven distinguished professionals and one patient advocacy organization with awards for their work to support the regulatory profession and advance public health. RAPS’ Founder’s Award, Community Leadership Award and Patient-Centered Health Award are presented annually during RAPS Convergence , the world’s largest conference dedicated to healthcare product regulation and regulatory issues. This year’s Convergence will take place virtually 12–15 Septemb...
  • RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    Chisholm, Falcone, Soo and Steffen named RAPS Fellows

    RAPS today announced the names of four exceptional senior regulatory professionals who will join the venerated ranks of RAPS Fellows . The 2021 RAPS Fellows are:   Orin Chisholm , FRAPS, BSc (Hons), GCULT, PhD, SFHEA, principal consultant, Pharmed, Sydney, Australia Robert Falcone , FRAPS, PhD, senior manager, regulatory affairs, Prestige Consumer Healthcare Inc., Tarrytown, NY Chin-Wei Soo , FRAPS, DRSc, global regulatory head, devices and combination products,...